HEMO-GE.ApS: Financial statements 2021
CVR: 39076322
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -4,375 and a net result of DKK 95,583 compared with DKK 96,002 the year before. Equity in the 2021 report amounted to DKK 1,989,374. The solvency ratio was 99.8%.
- Gross Profit
- DKK -4,375
- Profit/Loss
- DKK 95,583
- Equity
- DKK 1,989,374
- Total Assets
- DKK 1,993,224
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -4 t. | 96 t. | 2 mio. | - |
| 2020 | - | -4 t. | 96 t. | 2.1 mio. | - |
| 2019 | - | -4 t. | -5 t. | 2.1 mio. | - |
| 2018 | - | -7 t. | 194 t. | 2.2 mio. | - |
Official annual report
Find more companies like HEMO-GE.ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
HEMO-GE.ApS has published its interim report for the period July 1, 2020 – December 31, 2020.
About HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.